MLYS
Mineralys Therapeutics, Inc.
23.60$
-0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.6% | 99.0% | 99.9% | 99.8% | 99.8% | 99.7% | 99.9% | 99.9% | 100.0% | 99.9% | 99.9% | 99.7% | |
| 31.1% | 19.6% | 26.0% | 21.3% | 36.3% | 55.4% | 46.5% | 30.3% | 36.3% | 26.1% | 17.3% | 20.7% | |
| 91.4% | 94.0% | 97.5% | 97.7% | 98.3% | 96.3% | 96.6% | 96.8% | 36.3% | 99.2% | 99.0% | 99.0% | |
| 4.9% | 4.2% | 5.5% | 8.9% | 11.7% | 7.1% | 3.8% | 6.6% | 3.9% | 2.3% | 2.3% | 17.5% | |
| 4.9% | 4.2% | 5.5% | 8.9% | 11.7% | 7.1% | 3.8% | 6.6% | 3.9% | 2.3% | 2.3% | 2.9% | |
| 2.0% | 0.2% | 1.2% | 0.5% | 1.2% | 0.2% | 0.1% | 0.9% | 0.2% | 0.3% | 0.2% | 0.2% | |
| 95.1% | 95.8% | 94.5% | 91.1% | 88.3% | 92.9% | 96.2% | 93.4% | 96.1% | 97.7% | 97.7% | 82.5% | |
| -36.1% | -49.6% | -45.0% | -61.9% | -94.5% | -146.9% | -97.1% | -115.6% | -70.8% | -69.1% | -76.1% | -110.4% | |
| 14.4% | 15.9% | 12.9% | 15.5% | 18.6% | 24.3% | 15.0% | 19.5% | 11.8% | 12.2% | 12.7% | 12.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.